Improved survival of porcine acute liver failure by a bioartificial liver device implanted with induced human functional hepatocytes
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Acute liver failure (ALF) is a life-threatening illness. The extracorporeal cell-based bioartificial liver (BAL) system could bridge liver transplantation and facilitate liver regeneration for ALF patients by providing metabolic detoxification and synthetic functions. Previous BAL systems, based on hepatoma cells and non-human hepatocytes, achieved limited clinical advances, largely due to poor hepatic functions, cumbersome preparation or safety concerns of these cells. We previously generated human functional hepatocytes by lineage conversion (hiHeps). Here, by improving functional maturity of hiHeps and producing hiHeps at clinical scales (3 billion cells), we developed a hiHep-based BAL system (hiHep-BAL). In a porcine ALF model, hiHep-BAL treatment restored liver functions, corrected blood levels of ammonia and bilirubin, and prolonged survival. Importantly, human albumin and α-1-antitrypsin were detectable in hiHep-BAL-treated ALF pigs. Moreover, hiHep-BAL treatment led to attenuated liver damage, resolved inflammation and enhanced liver regeneration. Our findings indicate a promising clinical application of the hiHep-BAL system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bernal, W., & Wendon, J. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1208937 · Cited by 1,169
Bhatia, S. N., Balis, U. J., Yarmush, M. L., & Toner, M. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.14.1883 · Cited by 890
Induction of functional hepatocyte-like cells from mouse fibroblasts by defined factors
Huang, P., He, Z., Ji, S., Sun, H., Xiang, D., Liu, C., Hu, Y., Wang, X., & Hui, L. (2011) · Nature · doi:10.1038/nature10116 · Cited by 864 · cited 1×
“We have previously converted mouse and human fi - broblasts into functional hepatocytes [17, 18].”
Self-citationCell and tissue engineering for liver disease
Bhatia, S. N., Underhill, G. H., Zaret, K. S., & Fox, I. J. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3005975 · Cited by 309
Feng, Z.-Q., Chu, X., Huang, N.-P., Wang, T., Wang, Y., Shi, X., Ding, Y., & Gu, Z.-Z. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.01.053 · Cited by 216
Self-citation
Cited by
A decade of progress in liver regenerative medicine
Zhang, J., Zhao, X., Liang, L., Li, J., Demirci, U., & Wang, S. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2017.11.027 · Cited by 111
Self-citationChen, H. S., Joo, D. J., Shaheen, M., Li, Y., Wang, Y., Yang, J., Nicolas, C. T., Predmore, K., Amiot, B., Michalak, G., et al. (2019) · Hepatology · doi:10.1002/hep.30184 · Cited by 77
“(3-5) Newer generation devices have been modified to increase cell numbers and improve detoxification in large animal ALF models.(6-8) One such device is the spheroid reservoir bio-artificial liver (SRBAL), which showed a survival benefit and was associated with both a significant lowering of blood ammonia levels and…”
BackgroundResultEngineering Liver Microtissues for Disease Modeling and Regenerative Medicine
Huang, D. (., Gibeley, S. B., Xu, C., Xiao, Y., Celik, O., Ginsberg, H. N., & Leong, K. W. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201909553 · Cited by 65
Wang, Y., Zheng, Q., Sun, Z., Wang, C., Cen, J., Zhang, X., Jin, Y., Wu, B., Yan, T., Wang, Z., et al. (2023) · Cell Stem Cell · doi:10.1016/j.stem.2023.03.013 · Cited by 55
Self-citationJin, Y., Zhang, J., Xu, Y., Yi, K., Li, F., Zhou, H., Wang, H., Chan, H. F., Lao, Y.-H., Lv, S., et al. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2023.05.001 · Cited by 55
Gao, Y., Zhang, X., Zhang, L., Cen, J., Ni, X., Liao, X., Yang, C., Li, Y., Chen, X., Zhang, Z., et al. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.10.019 · Cited by 50
“1822 Stem Cell Reports j Vol. 9 j 1813–1824 j December 12, 2017 Despite the divergences between HLCs and PHHs, HLCs have been alreadyproveduseful for in vitrodiseasemodeling and cell-based therapies (Forbes et al., 2015; Shi et al., 2016).”
BackgroundSelf-citationLiver regeneration after injury: Mechanisms, cellular interactions and therapeutic innovations
Liu, Q., Wang, S., Fu, J., Chen, Y., Xu, J., Wei, W., Song, H., Zhao, X., & Wang, H. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.1812 · Cited by 49
Self-citationWu, G., Wu, D., Lo, J., Wang, Y., Wu, J., Lu, S., Xu, H., Zhao, X., He, Y., Li, J., et al. (2020) · Biomaterials Science · doi:10.1039/c9bm01879d · Cited by 28
Self-citationBioartificial livers: a review of their design and manufacture
Tuerxun, K., He, J., Ibrahim, I., Yusupu, Z., Yasheng, A., Xu, Q., Tang, R., Aikebaier, A., Wu, Y., Tuerdi, M., et al. (2022) · Biofabrication · doi:10.1088/1758-5090/ac6e86 · Cited by 24
“Given the advantages of hiHeps, Shi et al [71] produced a large scale culture of hiHeps (3 billion cells) in a BAL device for the treatment of ALF pigs.”
Stem Cell-Based Strategies: The Future Direction of Bioartificial Liver Development
Feng, L., Wang, Y., Fu, Y., Li, T., & He, G. (2024) · Stem Cell Reviews and Reports · doi:10.1007/s12015-023-10672-5 · Cited by 9
“F: Multi-layer radial-flow bioreactor and schematic diagram of treatment [197] bioreactors.”
Metadata
- Authors
- Shi, X.-L., Gao, Y., Yan, Y., Ma, H., Sun, L., Huang, P., Ni, X., Zhang, L., Zhao, X., Ren, H., Hu, D., Zhou, Y., Tian, F., Ji, Y., Cheng, X., Pan, G., Ding, Y.-T., & Hui, L.
- Venue
- Cell Research
- Published
- 2016-01-15
- Volume
- 26
- Issue
- 2
- Pages
- 206-216
- ISSN
- 1001-0602 (ISSN-L)
- 1748-7838
- OpenAlex
- W2338909632
- Cited by
- 133
- References
- 5
- FWCI
- 18.59
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.